Nancy Joseph‐Ridge

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · New England Journal of Medicine · 2005 · 1.3K citations · Full text

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial

H. Ralph Schumacher, Michael A. Becker, Robert L. Wortmann et al. · Arthritis Care & Research · 2008 · 623 citations

Renal Inflammation, Pharmacotherapy, Gout Flares +19

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.

Katrine L. Wallace, Aylin Riedel, Nancy Joseph‐Ridge et al. · PubMed · 2004 · 427 citations

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · Arthritis & Rheumatism · 2005 · 267 citations

Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.

Aylin Riedel, Michael A. Nelson, Nancy Joseph‐Ridge et al. · PubMed · 2004 · 175 citations